{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T07:00:05Z","timestamp":1769583605917,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,5,22]],"date-time":"2014-05-22T00:00:00Z","timestamp":1400716800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s00431-014-2332-4","type":"journal-article","created":{"date-parts":[[2014,5,21]],"date-time":"2014-05-21T05:53:47Z","timestamp":1400651627000},"page":"1355-1364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Erythropoietin and retinopathy of prematurity: a meta-analysis"],"prefix":"10.1007","volume":"173","author":[{"given":"Xu-Juan","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,22]]},"reference":[{"key":"2332_CR1","volume":"9","author":"SM Aher","year":"2012","unstructured":"Aher SM, Ohlsson A (2012) Late erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants. Cochrane Database Syst Rev 9, CD004868","journal-title":"Cochrane Database Syst Rev"},{"key":"2332_CR2","volume":"10","author":"SM Aher","year":"2012","unstructured":"Aher SM, Ohlsson A (2012) Early versus late erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants. Cochrane Database Syst Rev 10, CD004865","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2332_CR3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/112067210801800119","volume":"18","author":"R Autrata","year":"2008","unstructured":"Autrata R, Senkov\u00e1 K, Holousov\u00e1 M, Helmanov\u00e1 I, Pyrochtov\u00e1 S (2008) Combined treatment with laser photocoagulation and cryotherapy for threshold retinopathy of prematurity. Eur J Ophthalmol 18(1):112\u2013117","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"2332_CR4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cardiores.2006.06.026","volume":"72","author":"D Burger","year":"2006","unstructured":"Burger D, Lei M, Geoghegan-Morphet N, Lu X, Xenocostas A, Feng Q (2006) Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase. Cardiovasc Res 72(1):51\u201359","journal-title":"Cardiovasc Res"},{"issue":"2","key":"2332_CR5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10456-007-9066-0","volume":"10","author":"J Chen","year":"2007","unstructured":"Chen J, Smith LE (2007) Retinopathy of prematurity. Angiogenesis 10(2):133\u2013140","journal-title":"Angiogenesis"},{"issue":"3\u20134","key":"2332_CR6","first-page":"228","volume":"79","author":"C Dame","year":"2001","unstructured":"Dame C, Juul SE, Christensen RD (2001) The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential. Biol Neonate 79(3\u20134):228\u2013235","journal-title":"Biol Neonate"},{"issue":"1","key":"2332_CR7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0378-3782(01)00115-3","volume":"62","author":"C Dani","year":"2001","unstructured":"Dani C, Reali MF, Bertini G, Martelli E, Pezzati M, Rubaltelli FF (2001) The role of blood transfusions and iron intake on retinopathy of prematurity. Early Hum Dev 62(1):57\u201363","journal-title":"Early Hum Dev"},{"issue":"5","key":"2332_CR8","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1542\/peds.105.5.1066","volume":"105","author":"H Donato","year":"2000","unstructured":"Donato H, Vain N, Rendo P, Vivas N, Prudent L, Largu\u00eda M (2000) Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial. Pediatrics 105(5):1066\u20131072","journal-title":"Pediatrics"},{"issue":"2","key":"2332_CR9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1542\/peds.2007-2591","volume":"122","author":"JC Fauch\u00e8re","year":"2008","unstructured":"Fauch\u00e8re JC, Dame C, Vonthein R, Koller B, Arri S, Wolf M (2008) An approach to using recombinant erythropoietin for neuroprotection in very preterm infants. Pediatrics 122(2):375\u2013382","journal-title":"Pediatrics"},{"issue":"6","key":"2332_CR10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.anpedi.2010.09.001","volume":"73","author":"J Figueras-Aloy","year":"2010","unstructured":"Figueras-Aloy J, Alvarez-Dom\u00ednguez E, Morales-Ballus M, Salvia-Roiges MD, Moretones-Su\u00f1ol G (2010) Early administration of erythropoietin in the extreme premature, a risk factor for retinopathy of prematurity? An Pediatr (Barc) 73(6):327\u2013333","journal-title":"An Pediatr (Barc)"},{"issue":"2","key":"2332_CR11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","volume":"84","author":"C Gilbert","year":"2008","unstructured":"Gilbert C (2008) Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev 84(2):77\u201382","journal-title":"Early Hum Dev"},{"key":"2332_CR12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557\u2013560","journal-title":"BMJ"},{"key":"2332_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1\u201312","journal-title":"Control Clin Trials"},{"issue":"3","key":"2332_CR14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood.V77.3.419.419","volume":"77","author":"SB Krantz","year":"1991","unstructured":"Krantz SB (1991) Erythropoietin. Blood 77(3):419\u2013434","journal-title":"Blood"},{"issue":"3","key":"2332_CR15","first-page":"173","volume":"18","author":"P Kumar","year":"1998","unstructured":"Kumar P, Shankaran S, Krishnan RG (1998) Recombinant human erythropoietin therapy for treatment of anemia of prematurity in very low birth weight infants: a randomized, double-blind, placebo-controlled trial. J Perinatol 18(3):173\u2013177","journal-title":"J Perinatol"},{"issue":"1","key":"2332_CR16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1067\/mpd.2002.124309","volume":"141","author":"RF Maier","year":"2002","unstructured":"Maier RF, Obladen M, M\u00fcller-Hansen I, Kattner E, Merz U, Arlettaz R (2002) Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000\u00a0g. J Pediatr 141(1):8\u201315","journal-title":"J Pediatr"},{"issue":"20","key":"2332_CR17","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1056\/NEJM200511173532015","volume":"353","author":"P Manzoni","year":"2005","unstructured":"Manzoni P, Maestri A, Gomirato G (2005) Erythropoietin as a retinal angiogenic factor. N Engl J Med 353(20):2190\u20132191","journal-title":"N Engl J Med"},{"issue":"6","key":"2332_CR18","first-page":"634","volume":"4","author":"S Mehmet","year":"2011","unstructured":"Mehmet S, Fusun A, Sebnem C, Ozgur O, Gulten E, Taylan OA (2011) One-year experience in the retinopathy of prematurity: frequency and risk factors, short-term results and follow-up. Int J Ophthalmol 4(6):634\u2013640","journal-title":"Int J Ophthalmol"},{"issue":"6 Pt 1","key":"2332_CR19","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1542\/peds.93.6.918","volume":"93","author":"MP Meyer","year":"1994","unstructured":"Meyer MP, Meyer JH, Commerford A, Hann FM, Sive AA, Moller G (1994) Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study. Pediatrics 93(6 Pt 1):918\u2013923","journal-title":"Pediatrics"},{"issue":"1","key":"2332_CR20","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1542\/peds.2013-0143","volume":"132","author":"RK Ohls","year":"2013","unstructured":"Ohls RK, Christensen RD, Kamath-Rayne BD, Rosenberg A, Wiedmeier SE, Roohi M (2013) A randomized, masked, placebo-controlled study of darbepoetin alfa in preterm infants. Pediatrics 132(1):e119\u2013e127","journal-title":"Pediatrics"},{"issue":"4","key":"2332_CR21","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1542\/peds.108.4.934","volume":"108","author":"RK Ohls","year":"2001","unstructured":"Ohls RK, Ehrenkranz RA, Wright LL, Lemons JA, Korones SB, Stoll BJ (2001) Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250\u00a0grams birth weight: a multicenter, randomized, controlled trial. Pediatrics 108(4):934\u2013942","journal-title":"Pediatrics"},{"key":"2332_CR22","volume":"9","author":"A Ohlsson","year":"2012","unstructured":"Ohlsson A, Aher SM (2012) Early erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants. Cochrane Database Syst Rev 9, CD004863","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"2332_CR23","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/PL00008390","volume":"159","author":"C Romagnoli","year":"2000","unstructured":"Romagnoli C, Zecca E, Gallini F, Girlando P, Zuppa AA (2000) Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity? Eur J Pediatr 159(8):627\u2013628","journal-title":"Eur J Pediatr"},{"issue":"9","key":"2332_CR24","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ophtha.2008.12.023","volume":"116","author":"T Sato","year":"2009","unstructured":"Sato T, Kusaka S, Shimojo H, Fujikado T (2009) Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity. Ophthalmology 116(9):1599\u20131603","journal-title":"Ophthalmology"},{"issue":"11","key":"2332_CR25","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1592\/phco.28.11.1335","volume":"28","author":"JK Schneider","year":"2008","unstructured":"Schneider JK, Gardner DK, Cordero L (2008) Use of recombinant human erythropoietin and risk of severe retinopathy in extremely low-birth-weight infants. Pharmacotherapy 28(11):1335\u20131340","journal-title":"Pharmacotherapy"},{"issue":"1","key":"2332_CR26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/s-0029-1224872","volume":"27","author":"N Shah","year":"2010","unstructured":"Shah N, Jadav P, Jean-Baptiste D, Weedon J, Cohen LM, Kim MR (2010) The effect of recombinant human erythropoietin on the development of retinopathy of prematurity. Am J Perinatol 27(1):67\u201371","journal-title":"Am J Perinatol"},{"issue":"1","key":"2332_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.95.1.1","volume":"95","author":"KM Shannon","year":"1995","unstructured":"Shannon KM, Keith JF 3rd, Mentzer WC, Ehrenkranz RA, Brown MS, Widness JA (1995) Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 95(1):1\u20138","journal-title":"Pediatrics"},{"issue":"3","key":"2332_CR28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaapos.2007.08.009","volume":"12","author":"KK Suk","year":"2008","unstructured":"Suk KK, Dunbar JA, Liu A, Daher NS, Leng CK, Leng JK (2008) Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model. J AAPOS 12(3):233\u2013238","journal-title":"J AAPOS"},{"issue":"8","key":"2332_CR29","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1056\/NEJMoa041773","volume":"353","author":"D Watanabe","year":"2005","unstructured":"Watanabe D, Suzuma K, Matsui S, Kurimoto M, Kiryu J, Kita M (2005) Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med 353(8):782\u2013792","journal-title":"N Engl J Med"},{"key":"2332_CR30","unstructured":"Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M. The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Ottawa Health Research Institute. Available from: URL: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp . Assessed 20 Nov 2013"},{"issue":"10","key":"2332_CR31","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1167\/iovs.10-5283","volume":"51","author":"MA Zayed","year":"2010","unstructured":"Zayed MA, Uppal A, Hartnett ME (2010) New-onset maternal gestational hypertension and risk of retinopathy of prematurity. Invest Ophthalmol Vis Sci 51(10):4983\u20134988","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-014-2332-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-014-2332-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-014-2332-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T22:19:48Z","timestamp":1649024388000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-014-2332-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,22]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["2332"],"URL":"https:\/\/doi.org\/10.1007\/s00431-014-2332-4","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,22]]}}}